{"id":240652,"date":"2021-06-22T15:04:04","date_gmt":"2021-06-22T19:04:04","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=240652"},"modified":"2021-06-22T15:04:04","modified_gmt":"2021-06-22T19:04:04","slug":"abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/","title":{"rendered":"Abdala vaccine candidate: 92.28% efficacy in its three doses"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">The Center for Genetic Engineering and Biotechnology (CIGB) announced this Monday in Havana that the Cuban Abdala vaccine candidate has an efficacy of 92.28% with a scheme of three applied doses, according to the clinical studies of the immunogen.<\/span><\/p>\n<p><a href=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-240656\" src=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1.jpg\" alt=\"\" width=\"1280\" height=\"720\" srcset=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1.jpg 1280w, https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1-300x169.jpg 300w, https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1-1024x576.jpg 1024w, https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1-768x432.jpg 768w, https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1-750x422.jpg 750w, https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Farma-1-1140x641.jpg 1140w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/a><\/p>\n<p><span style=\"font-weight: 400;\">With these results, Abdala will be officially considered a vaccine against the new coronavirus, since the requirements demanded by the World Health Organization (WHO) for its approval establish a 50% efficiency for the registration of vaccines and for their authorization for emergency use.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cThe efficacy with three doses of Abdala will be an event that will swell our pride,\u201d tweeted President Miguel D\u00edaz-Canel, shortly before the news was released.<\/span><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"ZHAKfG6iLq\"><p><a href=\"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/cuban-soberana-02-vaccine-candidate-shows-62-efficacy-in-clinical-trials\/\">Cuban Soberana 02 vaccine candidate shows 62% efficacy in clinical trials<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Cuban Soberana 02 vaccine candidate shows 62% efficacy in clinical trials&#8221; &#8212; OnCubaNews English\" src=\"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/cuban-soberana-02-vaccine-candidate-shows-62-efficacy-in-clinical-trials\/embed\/#?secret=32TZMX450m#?secret=ZHAKfG6iLq\" data-secret=\"ZHAKfG6iLq\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p><span style=\"font-weight: 400;\">The announcement comes at a time when the island is experiencing an outbreak of the disease. And it comes two days after the authorities announced that Soberana 02, the other vaccine candidate that also completed its three phases of trials, reached an efficacy of 62% with two doses of the three planned with the immunizers developed in Cuba.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).<\/p>\n","protected":false},"author":3134,"featured_media":240655,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33393,13916],"tags":[33526,33386],"ppma_author":[33546],"class_list":["post-240652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus","category-science-in-cuba","tag-abdala","tag-cuban-vaccine-against-covid-19"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abdala vaccine candidate: 92.28% efficacy in its three doses | OnCubaNews English<\/title>\n<meta name=\"description\" content=\"The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abdala vaccine candidate: 92.28% efficacy in its three doses | OnCubaNews English\" \/>\n<meta property=\"og:description\" content=\"The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/\" \/>\n<meta property=\"og:site_name\" content=\"OnCubaNews English\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-22T19:04:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Centro-1-750x563-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"OnCuba Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"OnCuba Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/\"},\"author\":{\"name\":\"OnCuba Staff\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"headline\":\"Abdala vaccine candidate: 92.28% efficacy in its three doses\",\"datePublished\":\"2021-06-22T19:04:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/\"},\"wordCount\":180,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Centro-1-750x563-1.jpg\",\"keywords\":[\"Abdala\",\"Cuban vaccine against COVID-19\"],\"articleSection\":[\"Coronavirus\",\"Science in Cuba\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#respond\"]}],\"copyrightYear\":\"2021\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/\",\"name\":\"Abdala vaccine candidate: 92.28% efficacy in its three doses | OnCubaNews English\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Centro-1-750x563-1.jpg\",\"datePublished\":\"2021-06-22T19:04:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"description\":\"The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#primaryimage\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Centro-1-750x563-1.jpg\",\"contentUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/Centro-1-750x563-1.jpg\",\"width\":750,\"height\":563,\"caption\":\"Center for Genetic Engineering and Biotechnology (CIGB). Photo: Pinterest.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/coronavirus\\\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abdala vaccine candidate: 92.28% efficacy in its three doses\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\",\"name\":\"OnCubaNews English\",\"description\":\"Revista sobre Cuba\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\",\"name\":\"OnCuba Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"caption\":\"OnCuba Staff\"},\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/author\\\/oncuba-editorial-staff\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abdala vaccine candidate: 92.28% efficacy in its three doses | OnCubaNews English","description":"The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/","og_locale":"en_US","og_type":"article","og_title":"Abdala vaccine candidate: 92.28% efficacy in its three doses | OnCubaNews English","og_description":"The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).","og_url":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/","og_site_name":"OnCubaNews English","article_published_time":"2021-06-22T19:04:04+00:00","og_image":[{"width":750,"height":563,"url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Centro-1-750x563-1.jpg","type":"image\/jpeg"}],"author":"OnCuba Staff","twitter_card":"summary_large_image","twitter_misc":{"Written by":"OnCuba Staff","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#article","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/"},"author":{"name":"OnCuba Staff","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"headline":"Abdala vaccine candidate: 92.28% efficacy in its three doses","datePublished":"2021-06-22T19:04:04+00:00","mainEntityOfPage":{"@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/"},"wordCount":180,"commentCount":0,"image":{"@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Centro-1-750x563-1.jpg","keywords":["Abdala","Cuban vaccine against COVID-19"],"articleSection":["Coronavirus","Science in Cuba"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#respond"]}],"copyrightYear":"2021","copyrightHolder":{"@id":"https:\/\/oncubanews.com\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/","url":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/","name":"Abdala vaccine candidate: 92.28% efficacy in its three doses | OnCubaNews English","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#primaryimage"},"image":{"@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Centro-1-750x563-1.jpg","datePublished":"2021-06-22T19:04:04+00:00","author":{"@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"description":"The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).","breadcrumb":{"@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#primaryimage","url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Centro-1-750x563-1.jpg","contentUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/06\/Centro-1-750x563-1.jpg","width":750,"height":563,"caption":"Center for Genetic Engineering and Biotechnology (CIGB). Photo: Pinterest."},{"@type":"BreadcrumbList","@id":"https:\/\/oncubanews.com\/en\/coronavirus\/abdala-vaccine-candidate-92-28-efficacy-in-its-three-doses\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncubanews.com\/en\/"},{"@type":"ListItem","position":2,"name":"Abdala vaccine candidate: 92.28% efficacy in its three doses"}]},{"@type":"WebSite","@id":"https:\/\/oncubanews.com\/en\/#website","url":"https:\/\/oncubanews.com\/en\/","name":"OnCubaNews English","description":"Revista sobre Cuba","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncubanews.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af","name":"OnCuba Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a","url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","caption":"OnCuba Staff"},"url":"https:\/\/oncubanews.com\/en\/author\/oncuba-editorial-staff\/"}]}},"authors":[{"term_id":33546,"user_id":3134,"is_guest":0,"slug":"oncuba-editorial-staff","display_name":"OnCuba Staff","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/240652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/users\/3134"}],"replies":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/comments?post=240652"}],"version-history":[{"count":0,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/240652\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media\/240655"}],"wp:attachment":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media?parent=240652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/categories?post=240652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/tags?post=240652"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/ppma_author?post=240652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}